Sharon Leslie Bober, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sexual Dysfunction, Physiological | 23 | 2024 | 350 | 7.090 |
Why?
|
Sexual Dysfunctions, Psychological | 17 | 2024 | 190 | 5.160 |
Why?
|
Sexuality | 8 | 2019 | 168 | 2.380 |
Why?
|
Survivors | 18 | 2020 | 2302 | 1.880 |
Why?
|
Sexual Behavior | 18 | 2022 | 2045 | 1.790 |
Why?
|
Neoplasms | 27 | 2024 | 21681 | 1.360 |
Why?
|
Health Communication | 3 | 2022 | 210 | 1.190 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1087 | 0.890 |
Why?
|
Ovarian Neoplasms | 7 | 2023 | 4846 | 0.780 |
Why?
|
Medical Oncology | 3 | 2024 | 2269 | 0.780 |
Why?
|
Breast Neoplasms | 17 | 2022 | 20754 | 0.770 |
Why?
|
Body Image | 5 | 2020 | 623 | 0.740 |
Why?
|
Hematology | 1 | 2024 | 229 | 0.730 |
Why?
|
Communication | 11 | 2023 | 3783 | 0.710 |
Why?
|
Urologic Diseases | 1 | 2021 | 244 | 0.650 |
Why?
|
Psychotherapy, Group | 2 | 2019 | 411 | 0.620 |
Why?
|
Ovary | 2 | 2019 | 961 | 0.610 |
Why?
|
Health Personnel | 3 | 2021 | 3214 | 0.600 |
Why?
|
Quality of Life | 13 | 2024 | 12985 | 0.600 |
Why?
|
Self Efficacy | 2 | 2019 | 609 | 0.590 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2016 | 1510 | 0.530 |
Why?
|
Communication Barriers | 2 | 2021 | 400 | 0.530 |
Why?
|
Vaginal Diseases | 2 | 2016 | 103 | 0.530 |
Why?
|
Ovariectomy | 3 | 2023 | 610 | 0.520 |
Why?
|
Patient Education as Topic | 5 | 2017 | 2278 | 0.520 |
Why?
|
Libido | 1 | 2015 | 119 | 0.500 |
Why?
|
Salpingectomy | 1 | 2014 | 51 | 0.480 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 829 | 0.480 |
Why?
|
Menopause, Premature | 1 | 2015 | 125 | 0.470 |
Why?
|
Directive Counseling | 1 | 2014 | 167 | 0.440 |
Why?
|
Vagina | 1 | 2016 | 806 | 0.370 |
Why?
|
Hodgkin Disease | 2 | 2010 | 1378 | 0.370 |
Why?
|
Physician-Patient Relations | 8 | 2023 | 3189 | 0.370 |
Why?
|
Attitude of Health Personnel | 4 | 2021 | 3820 | 0.370 |
Why?
|
Physicians, Family | 2 | 2009 | 352 | 0.360 |
Why?
|
Stress, Psychological | 4 | 2021 | 4287 | 0.350 |
Why?
|
Interpersonal Relations | 5 | 2020 | 1410 | 0.340 |
Why?
|
Risk Reduction Behavior | 2 | 2022 | 1094 | 0.340 |
Why?
|
Gift Giving | 1 | 2009 | 76 | 0.320 |
Why?
|
Female | 45 | 2024 | 382129 | 0.310 |
Why?
|
Genetic Testing | 2 | 2020 | 3480 | 0.310 |
Why?
|
Adult | 34 | 2024 | 214969 | 0.300 |
Why?
|
Pediatrics | 2 | 2020 | 3559 | 0.300 |
Why?
|
Humans | 64 | 2024 | 746070 | 0.290 |
Why?
|
Mental Health | 1 | 2021 | 3091 | 0.280 |
Why?
|
Genes, BRCA2 | 1 | 2009 | 599 | 0.260 |
Why?
|
Young Adult | 16 | 2024 | 57114 | 0.250 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 930 | 0.250 |
Why?
|
Genes, BRCA1 | 1 | 2009 | 762 | 0.250 |
Why?
|
Qualitative Research | 4 | 2019 | 2840 | 0.240 |
Why?
|
Tamoxifen | 2 | 2007 | 957 | 0.230 |
Why?
|
Genetic Counseling | 1 | 2007 | 611 | 0.220 |
Why?
|
Sexual Partners | 5 | 2022 | 734 | 0.220 |
Why?
|
Health Care Surveys | 2 | 2016 | 2416 | 0.210 |
Why?
|
Couples Therapy | 2 | 2018 | 38 | 0.200 |
Why?
|
Adolescent | 15 | 2024 | 86212 | 0.190 |
Why?
|
Health Services Research | 1 | 2009 | 1809 | 0.190 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3408 | 0.180 |
Why?
|
Prostatic Neoplasms | 5 | 2022 | 11215 | 0.180 |
Why?
|
Adaptation, Psychological | 3 | 2022 | 2570 | 0.180 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 238 | 0.180 |
Why?
|
Mastectomy | 3 | 2015 | 1816 | 0.170 |
Why?
|
Male | 25 | 2024 | 351098 | 0.170 |
Why?
|
Spouses | 2 | 2018 | 268 | 0.170 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13531 | 0.170 |
Why?
|
Motivation | 1 | 2009 | 1963 | 0.160 |
Why?
|
Personal Satisfaction | 2 | 2014 | 636 | 0.160 |
Why?
|
Neoplasms, Second Primary | 1 | 2007 | 1053 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 248 | 0.150 |
Why?
|
Fertility | 2 | 2016 | 769 | 0.150 |
Why?
|
Memory | 1 | 2007 | 2165 | 0.150 |
Why?
|
Telephone | 2 | 2018 | 619 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 525 | 0.150 |
Why?
|
Complementary Therapies | 1 | 2021 | 479 | 0.150 |
Why?
|
Psychotherapy, Brief | 1 | 2017 | 115 | 0.140 |
Why?
|
Primary Health Care | 1 | 2013 | 4578 | 0.140 |
Why?
|
Vulvar Diseases | 1 | 2016 | 62 | 0.130 |
Why?
|
Estrogen Antagonists | 1 | 2015 | 151 | 0.120 |
Why?
|
Decision Making | 2 | 2009 | 3855 | 0.120 |
Why?
|
Infertility, Male | 1 | 2018 | 399 | 0.120 |
Why?
|
Age Factors | 3 | 2017 | 18145 | 0.120 |
Why?
|
Anxiety | 3 | 2021 | 4401 | 0.120 |
Why?
|
Middle Aged | 15 | 2024 | 214419 | 0.120 |
Why?
|
Cryopreservation | 1 | 2019 | 700 | 0.120 |
Why?
|
Consumer Health Information | 1 | 2016 | 208 | 0.110 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2019 | 1158 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1415 | 0.110 |
Why?
|
Pilot Projects | 4 | 2023 | 8370 | 0.100 |
Why?
|
Mass Screening | 2 | 2011 | 5329 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2009 | 7272 | 0.100 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2011 | 107 | 0.100 |
Why?
|
Delivery of Health Care | 1 | 2009 | 5236 | 0.100 |
Why?
|
Self Concept | 1 | 2017 | 1007 | 0.090 |
Why?
|
Radiotherapy | 1 | 2017 | 1504 | 0.090 |
Why?
|
Amenorrhea | 1 | 2014 | 497 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 7935 | 0.090 |
Why?
|
Women's Health | 2 | 2017 | 2035 | 0.090 |
Why?
|
BRCA2 Protein | 1 | 2014 | 789 | 0.090 |
Why?
|
Models, Psychological | 1 | 2013 | 802 | 0.080 |
Why?
|
Aged | 9 | 2024 | 164222 | 0.080 |
Why?
|
Patient Preference | 1 | 2016 | 891 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 5 | 2023 | 17435 | 0.080 |
Why?
|
Sexual Development | 1 | 2009 | 40 | 0.080 |
Why?
|
Colorado | 1 | 2009 | 164 | 0.080 |
Why?
|
Postal Service | 1 | 2009 | 93 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1597 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2018 | 5093 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1615 | 0.080 |
Why?
|
Fallopian Tubes | 1 | 2009 | 178 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1128 | 0.080 |
Why?
|
United States | 3 | 2024 | 70368 | 0.070 |
Why?
|
Professional Practice | 1 | 2009 | 311 | 0.070 |
Why?
|
Marriage | 1 | 2009 | 339 | 0.070 |
Why?
|
Arousal | 1 | 2012 | 1146 | 0.070 |
Why?
|
Depression | 2 | 2021 | 7826 | 0.070 |
Why?
|
Mammography | 2 | 2007 | 2425 | 0.070 |
Why?
|
Boston | 2 | 2010 | 9209 | 0.070 |
Why?
|
Child | 4 | 2024 | 78469 | 0.060 |
Why?
|
Long-Term Care | 1 | 2009 | 616 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 53219 | 0.060 |
Why?
|
Culture | 1 | 2009 | 620 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2892 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 38752 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8434 | 0.060 |
Why?
|
Data Collection | 2 | 2010 | 3287 | 0.060 |
Why?
|
Risk Factors | 4 | 2020 | 72413 | 0.060 |
Why?
|
Disease Management | 1 | 2013 | 2451 | 0.050 |
Why?
|
Physician's Role | 1 | 2009 | 911 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2007 | 1160 | 0.050 |
Why?
|
Chemoprevention | 1 | 2004 | 325 | 0.050 |
Why?
|
Internal Medicine | 1 | 2009 | 1024 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10095 | 0.050 |
Why?
|
Internet | 2 | 2017 | 3038 | 0.050 |
Why?
|
Focus Groups | 2 | 2017 | 1336 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1519 | 0.050 |
Why?
|
Orgasm | 1 | 2020 | 61 | 0.050 |
Why?
|
Medical History Taking | 1 | 2004 | 770 | 0.050 |
Why?
|
Cohort Studies | 3 | 2014 | 40505 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8509 | 0.040 |
Why?
|
Prevalence | 2 | 2020 | 15306 | 0.040 |
Why?
|
Massachusetts | 1 | 2012 | 8593 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2012 | 3716 | 0.040 |
Why?
|
Premenopause | 1 | 2023 | 1033 | 0.040 |
Why?
|
Puberty | 1 | 2021 | 490 | 0.040 |
Why?
|
Contraception | 1 | 2021 | 339 | 0.040 |
Why?
|
Learning | 1 | 2007 | 1718 | 0.040 |
Why?
|
Mutation | 2 | 2014 | 29620 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14114 | 0.040 |
Why?
|
Mental Health Services | 1 | 2008 | 1681 | 0.040 |
Why?
|
Counseling | 1 | 2004 | 1522 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2012 | 57552 | 0.030 |
Why?
|
Logistic Models | 1 | 2010 | 13164 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 684 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3542 | 0.030 |
Why?
|
Risk | 1 | 2007 | 9521 | 0.030 |
Why?
|
Needs Assessment | 1 | 2021 | 1132 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15341 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4265 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3011 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1257 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2010 | 21676 | 0.030 |
Why?
|
Life Style | 1 | 2022 | 3820 | 0.020 |
Why?
|
Emotions | 1 | 2022 | 2671 | 0.020 |
Why?
|
Child, Preschool | 2 | 2017 | 41383 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1389 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3124 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3204 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 29296 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3241 | 0.020 |
Why?
|
Psychometrics | 1 | 2011 | 2991 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25174 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6748 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14537 | 0.010 |
Why?
|
Infant | 1 | 2017 | 35448 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63664 | 0.010 |
Why?
|